|Articles|September 30, 2022
News Roundup: September 26 to September 30
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Supporting the Next Era of Independent Pharmacies in the US & Abroad
The future of independent pharmacy requires the combination of what makes independent pharmacy special and the digital landscape found elsewhere in retail.
Update on Using Dextromethorphan-Bupropion in Depression
A new—cough, cough—combination treatment for depression. Researchers performed an RCT of dextromethorphan-bupropion in major depressive disorder.
Is There a Link Between COVID-19 and Increased Type 1 Diabetes Diagnoses?
A pair of studies released within days of one another have produced conflicting reports related to the apparent increase in type 1 diabetes diagnoses following a COVID-19 infection in younger patients.
Program for Safer Opioid Supply Shows Positive Results
Positive effects emerge when patients get medical care, avoid deadly fentanyl-laced street drugs.
Adjustments in Drug Coverage Criteria in Health Plans Based on New Evidence
However, researchers found that only a small percentage of plans use available real-world evidence studies and economic evaluations in their coverage policies.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Vaccination of 3 Or More Doses Reduces Incidence of COVID-19 Symptoms for Young Adults
2
CVS Pharmacy Acquires Select Rite Aid Assets in 3 States, Accounting for Over 600 Stores
3
Introduction of PCV10 Reduces Pneumococcal Infections for Children
4
FDA Approves Afibercept-Boav as Biosimilar to Afibercept for Diabetic Macular Edema
5
